Interferon alpha-2b and ribavirin in combination for patients with chronic hepatitis C who failed to respond to, or relapsed after, interferon alpha therapy: a randomized trial
- 1 August 1999
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Medicine
- Vol. 107 (2) , 112-118
- https://doi.org/10.1016/s0002-9343(99)00160-6
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Combined treatment with interferon alpha‐2b and ribavirin for chronic hepatitis C in patients with a previous non‐response or non‐sustained response to interferon aloneJournal of Medical Virology, 1995
- A pilot study of combination therapy with ribavirin plus interferon alfa for interferon alfa-resistant chronic hepatitis CGastroenterology, 1994
- Ribavirin in the treatment of chronic hepatitis C unresponsive to alfa interferonJournal of Hepatology, 1993
- Hepatitis C viral RNA titers in serum prior to, during, and after oral treatment with ribavirin for chronic hepatitis CJournal of Medical Virology, 1993
- A Pilot Study of Ribavirin Therapy for Chronic Hepatitis CHepatology, 1992
- Interferon for non-A, non-B chronic hepatitis: A meta-analysis of randomised clinical trialsJournal of Hepatology, 1991
- Ribavirin treatment for chronic hepatitis CThe Lancet, 1991
- Recombinant Interferon Alfa Therapy for Chronic Hepatitis CNew England Journal of Medicine, 1989
- Treatment of Chronic Hepatitis C with Recombinant Interferon AlfaNew England Journal of Medicine, 1989
- A Randomized Controlled Open Study of Interferon Alpha-2b Treatment of Chronic IMon-A, Non-B Posttransfusion Hepatitis: No Correlation of Outcome to Presence of Hepatitis C Virus AntibodiesScandinavian Journal of Infectious Diseases, 1989